Kalmar Investments’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$5.04M Sell
64,952
-182,345
-74% -$12.6M 1.14% 44
2016
Q4
$16.6M Sell
247,297
-157,693
-39% -$9.72M 0.85% 59
2016
Q3
$24.3M Sell
404,990
-29,855
-7% -$1.66M 1.11% 28
2016
Q2
$21.8M Sell
434,845
-72,198
-14% -$3.44M 0.96% 38
2016
Q1
$22.8M Buy
507,043
+257,695
+103% +$9.18M 0.94% 41
2015
Q4
$10M Buy
249,348
+59,890
+32% +$2.53M 0.24% 122
2015
Q3
$9.2M Sell
189,458
-93,792
-33% -$4.45M 0.22% 127
2015
Q2
$12.6M Buy
+283,250
New +$10.9M 0.24% 123

Other funds holding INGN

Kalmar Investments's INGN Position: Q1 2017 in Review

Kalmar Investments reduced its Inogen (INGN) stake by 74% in Q1 2017, selling an estimated $12.6M and leaving 64,952 shares worth $5.04M. The position accounts for 1.14% of the portfolio, ranked #44.

Kalmar Investments first reported a position in INGN in Q2 2015 and has held it in 8 quarters since. The position peaked at $24.3M in Q3 2016. 194 funds tracked by Wall St. Rank hold INGN as of Q1 2017.

  • Kalmar Investments held 64,952 shares of Inogen worth $5.04M as of Q1 2017.
  • Kalmar Investments sold 182,345 Inogen shares in Q1 2017, an estimated $12.6M.
  • Inogen made up 1.14% of Kalmar Investments's portfolio in Q1 2017, its #44 holding.
  • Kalmar Investments first reported a position in Inogen in Q2 2015 and has held it in 8 quarters since.
  • Kalmar Investments's Inogen position peaked at $24.3M in Q3 2016.
  • 194 funds tracked by Wall St. Rank held Inogen as of Q1 2017.

Based on Kalmar Investments's 13F filing for Q1 2017, filed 26 Apr 2017.